British Medical Bulletin 61:81-96 (2002)
© 2002 Oxford University Press
Persistent and aggressive bacteria in the lungs of cystic fibrosis children
Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool, UK
There have been enormous improvements in life expectancy of patients with cystic fibrosis, especially with improved nutrition and better understanding of the basic cellular defects. However, infection in particular with Pseudomonas aeruginosa and Burkholderia cepacia, has the greatest effect in decreasing life expectancy. Although infections can be prevented by rigorous infection control procedures, early aggressive antimicrobial chemotherapy and established infection managed by antibiotics, they are not completely effective. A greater understanding of how the bacteria evade the host defences and produce infection is needed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Foweraker Recent advances in the microbiology of respiratory tract infection in cystic fibrosis Br. Med. Bull., March 1, 2009; 89(1): 93 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Overhage, A. Campisano, M. Bains, E. C. W. Torfs, B. H. A. Rehm, and R. E. W. Hancock Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation Infect. Immun., September 1, 2008; 76(9): 4176 - 4182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Overhage, S. Lewenza, A. K. Marr, and R. E. W. Hancock Identification of Genes Involved in Swarming Motility Using a Pseudomonas aeruginosa PAO1 Mini-Tn5-lux Mutant Library J. Bacteriol., March 1, 2007; 189(5): 2164 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Weaver and R. Kolter Burkholderia spp. Alter Pseudomonas aeruginosa Physiology through Iron Sequestration J. Bacteriol., April 15, 2004; 186(8): 2376 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roman, R. Canton, M. Perez-Vazquez, F. Baquero, and J. Campos Dynamics of Long-Term Colonization of Respiratory Tract by Haemophilus influenzae in Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable Strains J. Clin. Microbiol., April 1, 2004; 42(4): 1450 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Rogers, C. A. Hart, J. R. Mason, M. Hughes, M. J. Walshaw, and K. D. Bruce Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling J. Clin. Microbiol., August 1, 2003; 41(8): 3548 - 3558. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sahly, S. Schubert, J. Harder, P. Rautenberg, U. Ullmann, J. Schroder, and R. Podschun Burkholderia Is Highly Resistant to Human Beta-Defensin 3 Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1739 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Smalley, P. Charalabous, C. A. Hart, and J. Silver Transmissible Burkholderia cepacia genomovar IIIa strains bind and convert monomeric iron(III) protoporphyrin IX into the {micro}-oxo oligomeric form Microbiology, April 1, 2003; 149(4): 843 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. CANT, S.B. GORDON, R.C. READ, C.A. HART, and C. WINSTANLEY Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001 J. Med. Microbiol., November 1, 2002; 51(11): 903 - 914. [Full Text] [PDF] |
||||






